Product Images Ubrelvy

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 12 images provide visual information about the product associated with Ubrelvy NDC 0023-6498 by Allergan, Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

The following structural formula for UBRELVY is ubrogepant, a calcitonin gene-related peptide (CGRP) receptor antagonist. The chemical name of ubrogepant is (3'S)-N-((3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)piperidin-3-yl)-2'-oxo-1',2',5,7-tetrahydrospiro[cyclopenta[b]pyridine-6,3'-pyrrolo[2,3-b]pyridine]-3-carboxamide. - ubrelvy 01

Figure 1: Percentage of Patients Achieving Pain Freedom within 2 Hours in Pooled Studies 1 and 2 - ubrelvy 02

The text describes a graph displaying the percentage of individuals achieving pain freedom over time in hours from dose. The graph includes three data points at 60%, 80%, and 100%, as well as a fourth point labeled "409". The x-axis represents time in hours from the dose, ranging from 1 hour to 15 hours. There are two lines on the graph representing the medications UBRELVY 100 mg and UBRELVY 50 mg, as well as a line for the placebo group.*

Figure 2: Percentage of Patients Achieving MBS Freedom within 2 Hours in Pooled Studies 1 and 2 - ubrelvy 03

This appears to be a chart showing the effectiveness of UBRELVY, a medication available in 50 mg and 100 mg doses, compared to a placebo. The chart shows the percentage of people achieving a desired outcome over time after taking the medication or placebo. However, without knowing the desired outcome or more context, it's difficult to provide a more detailed description.*

Allergan - ubrelvy 05

NDC 0023-6498-02Ubrelvy(ubrogepant) tablet50 mgRx onlycontains 1 Tablet - ubrelvy 06

This is a description of UBRELVY® medication, which comes in tablets format of 50 mg of brogepant. It warns to keep the medication out of reach of children and provides storage instructions (between 20°C and 25°C). The text also indicates to refer to the package insert for more information and mentions a lot number of MY 12345.*

NDC 0023-6498-02Ubrelvy(ubrogepant) tablet50 mgRx onlycontains 1 Tablet - ubrelvy 07

UBRELVY is a medication available in tablet form, containing the active ingredient Ubrogepant. No additional information is available due to the limited text provided.*

NDC 0023-6498-10Ubrelvy(ubrogepant) tablets50 mgRx onlycontains 10 Tablets - ubrelvy 08

NDC 0023-6498-16Ubrelvy(ubrogepant) tablets50 mgRx onlycontains 16 Tablets - ubrelvy 09

UBRELVY is a type of medication that comes in tablet form and contains ubrogepant. Unfortunately, the results are incomplete and not correct, so additional information cannot be provided.*

NDC 0023-6498-30Ubrelvy(ubrogepant) tablets50 mgRx onlycontains 30 Tablets - ubrelvy 0a

UBRELVY® is a prescription medication available in 100 mg tablets. It is manufactured by Forest Laboratories and should be stored between 20°C and 25°C (68°F and 77°F). The LOT number for this medication is 12345.*

NDC 0023-6501-02Ubrelvy(ubrogepant) tablet100 mgRx onlycontains 1 Tablet - ubrelvy 0b

NDC 0023-6501-02Ubrelvy(ubrogepant) tablet100 mgRx onlycontains 1 Tablet - ubrelvy 0c

NDC 0023-6501-10Ubrelvy(ubrogepant) tablets100 mgRx onlycontains 10 Tablets - ubrelvy 0d

This is not-available as the text only contains jumbled words and characters.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.